Early radiographic response to epidermal growth factor receptor-tyrosine kinase inhibitor in non-small cell lung cancer patients with epidermal growth factor receptor mutations: A prospective study

Conclusions: A very high percentage (72.4%, 21/29) of NSCLC patients with EGFR mutations with PR demonstrates early radiological response to EGFR-TKIs, which would advocate early radiological examination for EGFR-TKI therapy in NSCLC patients.

http://www.biomedj.org/text.asp?2015/38/3/221/138320

Source: Biomedical Journal - June 11, 2015 Category: Biomedical Science Authors: John WC ChangMing-Mo HouJia-Juan HsiehYun-Chung CheungHung-Ming WangJen-Shi ChenCheng-Hsu WangChih-Hung ChenKun-Yun YehLi-Ying OuChia-Hsun HsiehHong-Dar Isaac WuYing-Tsong ChenIl-Chi ChangShiu-Feng Huang Source Type: research